Tesamorelin Peptide

Forty-four residues, a full development programme, and a Canadian postcode.

Tesamorelin is a 44 amino acid analogue of human growth hormone releasing hormone, modified at the N-terminus to resist enzymatic breakdown, and it stimulates the pituitary to release growth hormone. It is an approved prescription medicine sold as Egrifta, cleared by the FDA in November 2010 for HIV associated excess abdominal fat, approved by Health Canada but no longer marketed here, and never approved in Europe.

Here's a number that should bother you.

Of everything on this shelf, the count that ran a full development programme, survived every phase, and came out the other side with a regulator's signature is basically one.

Tesamorelin is a 44-residue analogue of GHRH, which is the hormone your hypothalamus sends to tell your pituitary to release growth hormone. Native GHRH is a fragile thing. DPP-4 finds it and cuts it inside minutes.

So the modification is a stabilising group on the N-terminus that stops the enzyme getting a grip.

Theratechnologies took it the whole way and the FDA approved it in 2010, for a specific condition in a specific patient population, under prescription and supervision.

None of which describes what is in this vial, or who is buying it. That approval belongs to a supervised medicine, not to research powder ordered online.

It doesn't do the job itself. It asks the pituitary to do the job.

Look, there are two ways to raise a signal in a system like this.

You can flood it from outside, or you can go upstream and ask the thing that already makes it to make a bit more.

That distinction matters more than it sounds. An upstream nudge still runs through the body's own feedback loops, which means the system keeps some say in the outcome.

The engineering problem was never getting GHRH to work. Your body proves it works several times a day. The problem was that GHRH is disposable by design and clears in minutes.

Here's the honest part. Everything above is mechanism, and mechanism is the easy half.

What it produces in a person was studied properly, under supervision, in a population selected for a trial. That is not the same as what happens to anybody who buys powder.

The rarest thing in this catalogue: a peptide that made it all the way through.

This one has a real file, and it is worth being precise about what kind of file it is.

A full development programme, phase 1 through 3, a regulatory submission, and an approval granted in 2010.

But read the approval carefully, because vendors love to quote the existence of it and skip the shape of it.

It was granted for one narrow indication, in one specific patient group, as a prescription product with medical oversight. The label is unusually explicit about what it is not approved for, and that sentence exists because people were always going to try.

An approval is a permission granted to a particular product for a particular use. It is not a general endorsement of a molecule, and anybody selling it as one is misreading the document on purpose.

Same day out of British Columbia. Our building, our cold packs, our people, and nothing sitting in a customs queue while you refresh a tracking page.

Then into the fridge. Keep it cold and keep it dark. Sealed and freeze-dried it handles a rough trip without ice. Once it lands, fridge.

Weight neutral, per the label. The FDA-approved label states it is not indicated for weight loss management as it has a weight neutral effect. It moves visceral fat. It does not reduce body weight. That is the manufacturer own wording and it is worth knowing before you buy.